Location History:
- Gardendale, AL (US) (1983 - 1986)
- Birmingham, AL (US) (1987)
- Hartselle, AL (US) (1988 - 2017)
Company Filing History:
7 out of 36 
7 out of 34 
3 out of 203 
Years Active: 1983-2017
Title: The Innovative Contributions of Danny H Lewis
Introduction
Danny H Lewis, based in Hartselle, Alabama, stands out as an accomplished inventor with a remarkable portfolio of 30 patents. His work primarily focuses on advancements in biopharmaceuticals and polymer technologies, showcasing his expertise in enhancing the efficiency of nucleic acid transfections and developing innovative drug delivery systems.
Latest Patents
Two of Lewis's latest patents highlight his cutting-edge contributions to the field of medical science. The first patent revolves around **nucleic acid-lipopolymer compositions**. This invention provides pharmaceutical compositions that significantly increase the efficiency of nucleic acid transfections. The formulations are characterized by a specific concentration of cationic lipopolymer combined with nucleic acids, suspended in an isotonic solution. The innovative design incorporates cholesterol and polyethylene glycol into the cationic polymer backbone, allowing for improved transfection profiles.
His second notable patent focuses on **site-specific insulin-polymer conjugates**. This invention outlines a streamlined method for preparing protein-polymer conjugates, particularly highlighting insulin. The process involves the use of organic solvents and metal chelators to facilitate the efficient formation of these conjugates, thus allowing for the targeted modification of proteins. Additionally, this patent presents a pharmaceutical formulation that encapsulates the conjugate within a biodegradable polymer, promising advancements in insulin delivery systems.
Career Highlights
Throughout his distinguished career, Danny H Lewis has contributed significantly to organizations such as Alkermes Controlled Therapeutics, Inc. and Stolle Research & Development Corporation. His experience in these leading companies enabled him to develop innovative solutions that push the boundaries of biopharmaceutical applications. His patents not only reflect his technical prowess but also underscore his commitment to addressing critical healthcare challenges.
Collaborations
Innovative endeavors often result from collaborative efforts. Lewis has worked alongside esteemed professionals like Michael E Rickey and J Michael Ramstack. These collaborations have played a crucial role in the development of his patents, pooling expertise and ideas to drive successful outcomes in their respective fields.
Conclusion
In summary, Danny H Lewis has emerged as a significant figure in the realm of innovation, particularly with his impressive portfolio of patents. His groundbreaking work in nucleic acid transfection and insulin delivery systems is paving the way for future advancements in the biotechnology sector. With a strong foundation built upon collaboration and deep industry knowledge, Lewis continues to make a profound impact on the world of biopharmaceutical innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.